AU2001273235A1 - Lipid metabolism molecules - Google Patents

Lipid metabolism molecules

Info

Publication number: AU2001273235A1
Authority: AU; Australia
Prior art keywords: lipid metabolism; metabolism molecules; molecules; lipid; metabolism
Prior art date: 2000-07-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU2001273235A

Inventor

Chandra S Arvizu

Yalda Azimzai

Mariah R. Baugn

Narinder K. Chawla

Debopriya Das

Vicki S. Elliott

Ameena R. Gandhi

April J. A. Hafalia

Farrah A. Khan

Preeti Lal

Dyung Aina M. Lu

Yan Lu

Danniel B. Nguyen

Jayalaxmi Ramkumar

Y. Tom Tang

Michael Thornton

Catherine M. Tribouley

Monique G. Yao

Henry Yue

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Incyte Corp

Original Assignee

Incyte Genomics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-07

Filing date

2001-07-06

Publication date

2002-01-21

2001-07-06 Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc

2002-01-21 Publication of AU2001273235A1 publication Critical patent/AU2001273235A1/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biomedical Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Wood Science & Technology (AREA)
Immunology (AREA)
Toxicology (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Neurology (AREA)
General Engineering & Computer Science (AREA)
Cardiology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Dermatology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

AU2001273235A 2000-07-07 2001-07-06 Lipid metabolism molecules Abandoned AU2001273235A1 (en)

Applications Claiming Priority (13)

Application Number	Priority Date	Filing Date	Title
US21680100P	2000-07-07	2000-07-07
US21680300P	2000-07-07	2000-07-07
US60/216,801		2000-07-07
US60/216,803		2000-07-07
US21823300P	2000-07-14	2000-07-14
US60/218,233		2000-07-14
US22004600P	2000-07-21	2000-07-21
US60/220,046		2000-07-21
US22073900P	2000-07-26	2000-07-26
US60/220,739		2000-07-26
US22282400P	2000-08-04	2000-08-04
US60/222,824		2000-08-04
PCT/US2001/021432 WO2002004490A2 (en)	2000-07-07	2001-07-06	Lipid metabolism molecules

Publications (1)

Publication Number	Publication Date
AU2001273235A1 true AU2001273235A1 (en)	2002-01-21

Family

ID=27559093

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2001273235A Abandoned AU2001273235A1 (en)	2000-07-07	2001-07-06	Lipid metabolism molecules

Country Status (5)

Country	Link
EP (1)	EP1313857A2 (en)
JP (1)	JP2004519207A (en)
AU (1)	AU2001273235A1 (en)
CA (1)	CA2414219A1 (en)
WO (1)	WO2002004490A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2389724A1 (en) *	1999-11-12	2001-05-17	Human Genome Sciences, Inc.	28 human secreted proteins
JPWO2002024923A1 (en) *	2000-09-19	2004-01-29	協和醗酵工業株式会社	Polypeptide having phospholipase A2 activity
AU2002212318A1 (en) *	2000-10-10	2002-04-22	Bayer Aktiengesellschaft	Regulation of human phospholipase a2-like enzyme
WO2002038773A2 (en)	2000-11-08	2002-05-16	Millennium Pharmaceuticals, Inc.	A human phospholipase c and uses thereof
AU2003203240A1 (en)	2002-01-17	2003-07-30	Tanabe Seiyaku Co., Ltd.	Novel phospholipase a2 and gene thereof
AU2003221383A1 (en) *	2002-03-14	2003-09-22	Kyowa Hakko Kogyo Co., Ltd.	Preventives or remedies for dermatitis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2001247395B2 (en) *	2000-03-13	2006-08-31	Lexicon Pharmaceuticals, Inc.	Novel human phospholipases and polynucleotides encoding the same
CA2407601A1 (en) *	2000-04-29	2001-11-08	Merck Patent Gesellschaft Mit Beschraenkter Haftung	Novel human phospholipase c delta 5

2001
- 2001-07-06 CA CA002414219A patent/CA2414219A1/en not_active Abandoned
- 2001-07-06 AU AU2001273235A patent/AU2001273235A1/en not_active Abandoned
- 2001-07-06 EP EP01952492A patent/EP1313857A2/en not_active Withdrawn
- 2001-07-06 WO PCT/US2001/021432 patent/WO2002004490A2/en not_active Ceased
- 2001-07-06 JP JP2002509353A patent/JP2004519207A/en active Pending

Also Published As

Publication number	Publication date
EP1313857A2 (en)	2003-05-28
CA2414219A1 (en)	2002-01-17
WO2002004490A3 (en)	2003-03-20
WO2002004490A2 (en)	2002-01-17
JP2004519207A (en)	2004-07-02

Publication	Publication Date	Title
AU2001277969A1 (en)	2002-02-13	Direct internet advertising
AU2001280710A1 (en)	2002-02-13	Internet advertising
AU4211600A (en)	2000-11-14	Modified lipid production
AUPQ339899A0 (en)	1999-11-04	Novel molecules
AU2001264055A1 (en)	2001-12-17	Display assembly
AU2002245332A1 (en)	2002-08-12	Anergy-regulated molecules
AU2002337312A1 (en)	2003-05-06	Molecules
AU2001281636A1 (en)	2002-03-26	Advertising
AU2001294245A1 (en)	2002-06-27	Compositions for improving lipid metabolism
AU5018900A (en)	2000-12-18	Lipid metabolism transcription factor
AU2001231053A1 (en)	2001-07-31	Lipid metabolism enzymes
AU2002217384A1 (en)	2002-09-05	Anti-allergic complex molecules
AU2001273235A1 (en)	2002-01-21	Lipid metabolism molecules
AU2001287022A1 (en)	2002-03-22	Secretory molecules
AU2001245397A1 (en)	2001-09-12	Lipid metabolism enzymes
AU2001230342A1 (en)	2001-08-07	Display unit
AU2002211005A1 (en)	2002-05-21	Lipid peroxide-lowering compositions
AU2002239632A1 (en)	2002-06-24	Display housing
AU2001257427A1 (en)	2001-11-12	Rna metabolism proteins
AU2001261424A1 (en)	2001-11-20	Lipid metabolism enzymes
AU2001236631A1 (en)	2001-09-03	Secretory molecules
AUPQ900200A0 (en)	2000-08-17	Display means
AU2002224352A1 (en)	2002-04-15	Lipid metabolism enzymes
AU2001286678A1 (en)	2002-03-04	Lipid metabolism enzymes
AU2002236594A1 (en)	2002-06-18	Lipid-associated molecules